Literature DB >> 14673008

Mitogen-activated protein kinase signaling in the hippocampus and its modulation by corticotropin-releasing factor receptor 2: a possible link between stress and fear memory.

Farahnaz Sananbenesi1, André Fischer, Christina Schrick, Joachim Spiess, Jelena Radulovic.   

Abstract

A coordinated activation of multiple interlinked signaling pathways involving cAMP-dependent protein kinase (PKA) and mitogen-activated extracellular signal-regulated kinases (Mek-1/2) regulates gene expression and neuronal changes underlying memory consolidation. In the present study we investigated whether these molecular cascades might mediate the effects of stress on memory formation. We also investigated the role of hippocampal corticotropin-releasing factor receptor 2 (CRF2) in stress-enhanced learning and molecular signaling mediated by PKA, Mek-1/2, and their downstream targets extracellularly regulated kinases 1 and 2 (Erk-1/2) and p90-ribosomal-s-kinase-1 (p90Rsk-1). Acute 1 hr immobilization was used as a stressful stimulus, and one-trial context-dependent fear conditioning was used as a model for associative learning. Training of BALB/c mice 3 hr after the end of immobilization resulted in an enhancement of conditioned fear, as indicated by significantly increased freezing behavior of stressed when compared with nonstressed mice. Interestingly, Erk-1/2 phosphorylation after conditioning of nonstressed and stressed mice depended on PKA and Mek-1/2, respectively. Intrahippocampal injection of the selective Mek-1/2 inhibitor U0126 or CRF2 antagonist antisauvagine-30 (aSvg-30) prevented stress-enhanced fear conditioning and Mek-1/2-dependent activation of Erk-1/2 and p90Rsk-1. aSvg-30 did not affect the phosphorylation of the PKA regulatory subunit II of stressed mice. The molecular and behavioral effects of CRF2 coincided with stress-induced upregulation of CRF2 mRNA. These results suggest that modulation of Mek-1/2-dependent signaling by hippocampal CRF2 can be selectively involved in the delayed effects of stress on memory consolidation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14673008      PMCID: PMC6740521     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  54 in total

1.  ERK plays a regulatory role in induction of LTP by theta frequency stimulation and its modulation by beta-adrenergic receptors.

Authors:  D G Winder; K C Martin; I A Muzzio; D Rohrer; A Chruscinski; B Kobilka; E R Kandel
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

2.  Role of regional neurotransmitter receptors in corticotropin-releasing factor (CRF)-mediated modulation of fear conditioning.

Authors:  J Radulovic; A Fischer; U Katerkamp; J Spiess
Journal:  Neuropharmacology       Date:  2000-02-14       Impact factor: 5.250

3.  The MAPK cascade is required for mammalian associative learning.

Authors:  C M Atkins; J C Selcher; J J Petraitis; J M Trzaskos; J D Sweatt
Journal:  Nat Neurosci       Date:  1998-11       Impact factor: 24.884

4.  Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning.

Authors:  G E Schafe; C M Atkins; M W Swank; E P Bauer; J D Sweatt; J E LeDoux
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

5.  The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus.

Authors:  E D Roberson; J D English; J P Adams; J C Selcher; C Kondratick; J D Sweatt
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

6.  Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2.

Authors:  S C Coste; R A Kesterson; K A Heldwein; S L Stevens; A D Heard; J H Hollis; S E Murray; J K Hill; G A Pantely; A R Hohimer; D C Hatton; T J Phillips; D A Finn; M J Low; M B Rittenberg; P Stenzel; M P Stenzel-Poore
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

7.  Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

Authors:  T Kishimoto; J Radulovic; M Radulovic; C R Lin; C Schrick; F Hooshmand; O Hermanson; M G Rosenfeld; J Spiess
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

8.  Corticotropin-releasing factor type 1 and type 2alpha receptors regulate phosphorylation of calcium/cyclic adenosine 3',5'-monophosphate response element-binding protein and activation of p42/p44 mitogen-activated protein kinase.

Authors:  C J Rossant; R D Pinnock; J Hughes; M D Hall; S McNulty
Journal:  Endocrinology       Date:  1999-04       Impact factor: 4.736

9.  Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2.

Authors:  J Radulovic; A Rühmann; T Liepold; J Spiess
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

10.  Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse.

Authors:  K Van Pett; V Viau; J C Bittencourt; R K Chan; H Y Li; C Arias; G S Prins; M Perrin; W Vale; P E Sawchenko
Journal:  J Comp Neurol       Date:  2000-12-11       Impact factor: 3.215

View more
  40 in total

Review 1.  Molecular specificity of multiple hippocampal processes governing fear extinction.

Authors:  Jelena Radulovic; Natalie C Tronson
Journal:  Rev Neurosci       Date:  2010       Impact factor: 4.353

2.  Hippocampal extracellular signal-regulated kinase signaling has a role in passive avoidance memory retrieval induced by GABAA Receptor modulation in mice.

Authors:  Dong Hyun Kim; Jong Min Kim; Se Jin Park; Seungheon Lee; Chan Young Shin; Jae Hoon Cheong; Jong Hoon Ryu
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

3.  Susceptibility to PTSD-like behavior is mediated by corticotropin-releasing factor receptor type 2 levels in the bed nucleus of the stria terminalis.

Authors:  Maya Lebow; Adi Neufeld-Cohen; Yael Kuperman; Michael Tsoory; Shosh Gil; Alon Chen
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

4.  Hippocampal Mek/Erk signaling mediates extinction of contextual freezing behavior.

Authors:  Andre Fischer; Marko Radulovic; Christina Schrick; Farahnaz Sananbenesi; Jasminka Godovac-Zimmermann; Jelena Radulovic
Journal:  Neurobiol Learn Mem       Date:  2006-09-18       Impact factor: 2.877

5.  Effects of social isolation on mRNA expression for corticotrophin-releasing hormone receptors in prairie voles.

Authors:  Hossein Pournajafi-Nazarloo; Leila Partoo; Jason Yee; Jennifer Stevenson; Lisa Sanzenbacher; William Kenkel; Seyed Ramezan Mohsenpour; Kozo Hashimoto; C Sue Carter
Journal:  Psychoneuroendocrinology       Date:  2010-11-20       Impact factor: 4.905

6.  Comparative analysis of the activation of MAP/ERK kinases in the CNS of animals with different learning abilities.

Authors:  L N Grinkevich; P D Lisachev; K A Baranova; O A Kharchenko
Journal:  Neurosci Behav Physiol       Date:  2007-09

7.  Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.

Authors:  Richard L Hauger; J Alberto Olivares-Reyes; Sandra Braun; Judith Hernandez-Aranda; Christine C Hudson; Eric Gutknecht; Frank M Dautzenberg; Robert H Oakley
Journal:  Regul Pept       Date:  2013-06-29

Review 8.  Role of corticotropin releasing factor in anxiety disorders: a translational research perspective.

Authors:  Victoria B Risbrough; Murray B Stein
Journal:  Horm Behav       Date:  2006-07-25       Impact factor: 3.587

Review 9.  Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction.

Authors:  Dimitris K Grammatopoulos
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

10.  Regulatory mechanisms of fear extinction and depression-like behavior.

Authors:  Natalie C Tronson; Christina Schrick; Andre Fischer; Farahnaz Sananbenesi; Gilles Pagès; Jacques Pouysségur; Jelena Radulovic
Journal:  Neuropsychopharmacology       Date:  2007-08-22       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.